1 |
Vuksan V, Sievenpipper J, Jovanovski E, Jenkins AL. Current clinical evidence for Korean red ginseng in management of diabetes and vascular disease: a Toronto's Ginseng Clinical Testing Program. J Ginseng Res 2010;34:264-273.
DOI
ScienceOn
|
2 |
Abdel-Wahhab MA, Gamil K, El-Kady AA, El-Nekeety AA, Naguib KM. Therapeutic effects of Korean red ginseng extract in Egyptian patients with chronic liver diseases. J Ginseng Res 2011;35:69-79.
과학기술학회마을
DOI
ScienceOn
|
3 |
Lee KG, Son SW. Efficacy of Korean red ginseng in the treatment of atopic dermatitis. J Ginseng Res 2011;35: 149-154.
과학기술학회마을
DOI
ScienceOn
|
4 |
Kim JH, Yi SM, Choi JE, Son SW. Study of the efficacy of Korean red ginseng in the treatment of androgenic alopecia. J Ginseng Res 2009;33:223-228.
과학기술학회마을
DOI
ScienceOn
|
5 |
Kim SH, Jeong KS, Ryu SY, Kim TH. Panax ginseng prevents apoptosis in hair follicles and accelerates recovery of hair medullary cells in irradiated mice. In Vivo 1998;12:219-222.
|
6 |
Matsuda H, Yamazaki M, Asanuma Y, Kubo M. Promotion of hair growth by ginseng radix on cultured mouse vibrissal hair follicles. Phytother Res 2003;17:797-800.
DOI
ScienceOn
|
7 |
Park EK, Choo MK, Han MJ, Kim DH. Ginsenoside Rh1 possesses antiallergic and anti-infl ammatory activities. Int Arch Allergy Immunol 2004;133:113-120.
DOI
ScienceOn
|
8 |
Ernst E. Panax ginseng: an overview of the clinical evidence. J Ginseng Res 2010;34:259-263.
과학기술학회마을
DOI
ScienceOn
|
9 |
Safavi K. Prevalence of alopecia areata in the First National Health and Nutrition Examination Survey. Arch Dermatol 1992;128:702.
|
10 |
Safavi KH, Muller SA, Suman VJ, Moshell AN, Melton LJ 3rd. Incidence of alopecia areata in Olmsted County, Minnesota, 1975 through 1989. Mayo Clin Proc 1995;70:628-633.
DOI
ScienceOn
|
11 |
Shapiro J, Madani S. Alopecia areata: diagnosis and management. Int J Dermatol 1999;38 Suppl 1:19-24.
DOI
|
12 |
Gupta MA, Gupta AK, Watteel GN. Stress and alopecia areata: a psychodermatologic study. Acta Derm Venereol 1997;77:296-298.
|
13 |
Canfi eld D. Photographic documentation of hair growth in androgenetic alopecia. Dermatol Clin 1996;14:713-721.
DOI
|
14 |
Lu W, Shapiro J, Yu M, Barekatain A, Lo B, Finner A, McElwee K. Alopecia areata: pathogenesis and potential for therapy. Expert Rev Mol Med 2006;8:1-19.
|
15 |
Alkhalifah A, Alsantali A, Wang E, McElwee KJ, Shapiro J. Alopecia areata update. Part I. Clinical picture, histopathology, and pathogenesis. J Am Acad Dermatol 2010;62:177-188.
DOI
ScienceOn
|
16 |
Tosti A, Bellavista S, Iorizzo M. Alopecia areata: a long term follow-up study of 191 patients. J Am Acad Dermatol 2006;55:438-441.
DOI
ScienceOn
|
17 |
Lew BL, Shin MK, Sim WY. Acute diffuse and total alopecia: a new subtype of alopecia areata with a favorable prognosis. J Am Acad Dermatol 2009;60:85-93.
DOI
ScienceOn
|
18 |
McDonagh AJ, Tazi-Ahnini R. Epidemiology and genetics of alopecia areata. Clin Exp Dermatol 2002;27:405-409.
DOI
ScienceOn
|
19 |
Paus R, Slominski A, Czarnetzki BM. Is alopecia areata an autoimmune-response against melanogenesis-related proteins, exposed by abnormal MHC class I expression in the anagen hair bulb? Yale J Biol Med 1993;66:541-554.
|
20 |
McElwee KJ, Tobin DJ, Bystryn JC, King LE Jr, Sundberg JP. Alopecia areata: an autoimmune disease? Exp Dermatol 1999;8:371-379.
DOI
ScienceOn
|
21 |
Delamere FM, Sladden MM, Dobbins HM, Leonardi-Bee J. Interventions for alopecia areata. Cochrane Database Syst Rev 2008;(2):CD004413.
|
22 |
Abell E, Munro DD. Intralesional treatment of alopecia areata with triamcinolone acetonide by jet injector. Br J Dermatol 1973;88:55-59.
|
23 |
Madani S, Shapiro J. Alopecia areata update. J Am Acad Dermatol 2000;42:549-566.
DOI
|
24 |
Wasserman D, Guzman-Sanchez DA, Scott K, McMichael A. Alopecia areata. Int J Dermatol 2007;46:121-131.
DOI
ScienceOn
|